Dr Colin Story
Non-Executive Director

Dr Colin Story brings over 25 years of medical technology and life sciences industry experience. After graduating with a BSc degree in Biological Sciences and a PhD in Molecular Biology he started his career at Amersham plc (now GE Healthcare) progressing through Product Development and Project Management roles to head a global commercial role with full P&L accountability for a £20m product portfolio. In 2005 he joined Isis Innovation Ltd, establishing a Business Development team to manage over 200 medical science innovations emanating from Oxford University. In 2011 he was invited to join OrganOx Ltd as Operations Director, seeing the business take its class III medical device from prototype through to successful completion of first in human clinical trials. Dr Story co-founded OxSonics in 2013 and served as Chief Executive Officer from January 2014 to January 2022. Under his leadership, a total of £25m was raised across three financing rounds, and OxSonics’ proprietary ‘SonoTran’ platform technology transitioned into clinical use. He built out the executive team of 30 and the board. He also led OxSonics through a corporate restructuring in 2016 to form sister company OrthoSon Limited, raising £1m seed capital and serving on the board as a Non-Executive Director for 6 years. Dr Story joined BetaGlue Technologies SpA as CEO and board director in February 2023.